Evidence map›Paper›PMID 35217664›Full record

ArticleNature communications2022

A mechanism of origin licensing control through autoinhibition of S. cerevisiae ORC·DNA·Cdc6.

Jan Marten Schmidt, Ran Yang, Ashish Kumar, Olivia Hunker, Jan Seebacher, Franziska Bleichert

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. A Meier-Gorlin syndrome mutation impairs the loading of the MCM2-7 complex during DNA replication initiation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. An Orc6 tether mediates ORC binding-site switching during replication origin licensing.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Changing protein-DNA interactions promote ORC binding-site exchange during replication origin licensing.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Regulation of replication origin licensing by ORC phosphorylation reveals a two-step mechanism for Mcm2-7 ring closing.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jan Marten Schmidt *Friedrich Miescher Institute for Biomedical Research, Basel, 4058, Switzerland.
Ran Yang *Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA.
Ashish KumarDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA.
Olivia HunkerDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA.
Jan SeebacherFriedrich Miescher Institute for Biomedical Research, Basel, 4058, Switzerland.ORCID http://orcid.org/0000-0002-7858-2720
Franziska BleichertDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06520, USA. franziska.bleichert@yale.edu.ORCID http://orcid.org/0000-0003-0014-770X
Yale University · USFriedrich Miescher Institute · CHNovartis (Switzerland) · CH

Funding

PREDOCTORAL PROGRAM IN BIOPHYSICST32GM008283 · NIGMS · YALE UNIVERSITY · PI XIONG, YONG · 1988 to 2022
$10.5M
Predoctoral Program in BiophysicsT32GM149438 · NIGMS · YALE UNIVERSITY · PI Yong Xiong, Elsa Chui Ying Yan · 2023 to 2026
$2.6M
Mechanisms for recruitment and function of metazoan replication initiation factorsR01GM141313 · NIGMS · YALE UNIVERSITY · PI BLEICHERT, FRANZISKA · 2021 to 2025
$1.7M
NIGMS NIH HHS R01 GM141313NIGMS NIH HHS T32 GM008283NIGMS NIH HHS T32 GM149438
6 · The paper itself

Abstract

The coordinated action of multiple replicative helicase loading factors is needed for the licensing of replication origins prior to DNA replication. Binding of the Origin Recognition Complex (ORC) to DNA initiates the ATP-dependent recruitment of Cdc6, Cdt1 and Mcm2-7 loading, but the structural details for timely ATPase site regulation and for how loading can be impeded by inhibitory signals, such as cyclin-dependent kinase phosphorylation, are unknown. Using cryo-electron microscopy, we have determined several structures of S. cerevisiae ORC·DNA·Cdc6 intermediates at 2.5-2.7 Å resolution. These structures reveal distinct ring conformations of the initiator·co-loader assembly and inactive ATPase site configurations for ORC and Cdc6. The Orc6 N-terminal domain laterally engages the ORC·Cdc6 ring in a manner that is incompatible with productive Mcm2-7 docking, while deletion of this Orc6 region alleviates the CDK-mediated inhibition of Mcm7 recruitment. Our findings support a model in which Orc6 promotes the assembly of an autoinhibited ORC·DNA·Cdc6 intermediate to block origin licensing in response to CDK phosphorylation and to avert DNA re-replication.

Indexed as

Cell Cycle ProteinsOrigin Recognition ComplexSaccharomyces cerevisiae ProteinsCryoelectron MicroscopyCyclin-Dependent KinasesDNADNA HelicasesDNA ReplicationMinichromosome Maintenance Complex Component 7Protein BindingReplication OriginSaccharomyces cerevisiaeCDC6 protein, S cerevisiaeCell Cycle ProteinsCyclin-Dependent KinasesDNADNA HelicasesMCM7 protein, S cerevisiaeMinichromosome Maintenance Complex Component 7Origin Recognition ComplexSaccharomyces cerevisiae Proteins

Identifiers

PMID35217664
PMCPMC8881611
OpenAlexW4214534632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.